Aurinia Pharmaceuticals Files 8-K
Ticker: AUPH · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1600620
| Field | Detail |
|---|---|
| Company | Aurinia Pharmaceuticals Inc. (AUPH) |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Aurinia Pharma filed an 8-K on 6/30/25 for 'Other Events' - details TBD.
AI Summary
Aurinia Pharmaceuticals Inc. filed an 8-K on June 30, 2025, to report other events. The filing does not contain specific details about the nature of these events, their financial impact, or any associated dates beyond the filing date itself.
Why It Matters
This 8-K filing indicates that Aurinia Pharmaceuticals Inc. has reported an event to the SEC, but the specific details of this event are not disclosed in the provided text.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' without immediate disclosed financial or operational impact.
Key Players & Entities
- Aurinia Pharmaceuticals Inc. (company) — Registrant
- 0001600620-25-000083 (document_id) — Accession Number
- June 30, 2025 (date) — Filing Date
FAQ
What specific event is Aurinia Pharmaceuticals Inc. reporting in this 8-K filing?
The provided text of the 8-K filing states that it is for 'Other Events' but does not specify the nature of the event.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 30, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at #140, 14315 - 118 Avenue, Edmonton, Alberta T5L 4S6.
What is the IRS Employer Identification Number for Aurinia Pharmaceuticals Inc.?
The IRS Employer Identification Number for Aurinia Pharmaceuticals Inc. is 98-1231763.
What is the SIC code for Aurinia Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Aurinia Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Aurinia Pharmaceuticals Inc. (AUPH).